BioPerfectus, a public listed company at Shanghai Stock Exchange (SSE:688399), is one of the leading molecular diagnostic solution providers in global in-vitro diagnostic market since 2010.
ABOUT US
One of the leading molecular diagnostic solution providers in global in-vitro diagnostic market since 2010.
PRODUCTS
Bioperfectus is key real-time PCR product supplier for Chinese disease prevention and control market.
NEWS
Company news and information of Jiangsu Bioperfectus Technology Co. Ltd..